Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc. has revised its 2025 funds from operations (FFO) estimate upward to $2.81 per share, reflecting a stronger investment volume than previously anticipated. Additionally, the normalized FFO estimate has been increased to $2.95 per share, enhancing confidence in the company's operational performance. With a year-to-date stock performance of +12%, significantly outpacing the +4% return of the VNQ index, Omega is also trading near the upper end of its 10-year valuation range, indicating strong market positioning and financial prospects.

Bears say

Omega Healthcare Investors Inc. faces significant challenges stemming from operator difficulties within the long-term healthcare sector, which contribute to a cautious outlook on the company's performance. Additionally, concerns regarding the company's relative valuation persist amid these operator challenges, hindering a more optimistic assessment. While the company's adjusted funds from operations (FFO) estimate for 2026 has slightly increased to $3.22 per share, it remains uncertain whether this growth will alleviate the broader concerns affecting its stock.

OHI has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 8 analysts, OHI has a Buy consensus rating as of Jan 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.